ArticleLeukemia2019

Correction: Bone marrow MSCs in MDS: contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy.

Zhiyong Poon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.